$170 MILLION MEDICAID FRAUD VERDICT
One Icelandic generic drug maker, Actavis, had the temerity to take an Average Wholesale Price fraud case to jury trial. The result: a $170 million judgment and likely exclusion from Texas Medicaid for Actavis, the privately-held generic drug maker that acquired Purepac and Alpharma pharmaceuticals. To date, the Texas Attorney General’s office has settled or won judgments for over $425 million against 13 drug companies.